Rationally Engineering Pro‐Proteins and Membrane‐Penetrating α‑Helical Polypeptides for Genome Editing Toward Choroidal Neovascularization Treatment
Advanced Materials · 2025
DOI: 10.1002/adma.202412366 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2025. Verfasst von Xun Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China. Hauptthemen laut MEDLINE: Choroidal Neovascularization, Gene Editing, Peptides, Protein Engineering. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China, Jiangsu Key Research and Development Plan.
Abstract (Originalsprache)
Ribonucleoprotein (RNP)‐based CRISPR/Cas9 genome editing holds great potential for the treatment of choroidal neovascularization (CNV), which however, is challenged by the lack of efficient cytosolic protein delivery tools. Herein, reversibly‐phosphorylated pro‐proteins (P‐proteins) with conjugated adenosine triphosphate (ATP) tags are engineered and coupled with a membrane‐penetrating, guanidine‐enriched, α‐helical polypeptide ( L GP) to mediate robust and universal cytosolic delivery. L GP forms salt‐stable nanocomplexes (NCs) with P‐proteins via electrostatic interaction and salt bridging, and the helix‐assisted, strong membrane activities of L GP enabled efficient cellular internalization and endolysosomal escape of NCs. Therefore, this approach allows efficient cytosolic delivery of a wide range of protein cargoes and maintains their bioactivities due to endolysosomal acidity‐triggered traceless restoration of P‐proteins. Notably, intravitreally delivered L GP/P‐RNP NCs targeting hypoxia‐inducible factor‐1α (HIF‐1α) induce pronounced gene disruption to downregulate pro‐angiogenic factors and alleviate subretinal fibrosis, ultimately provoking robust therapeutic efficacy in CNV mice. Such a facile and versatile platform provides a powerful tool for cytosolic protein delivery and genome editing, and it holds promising potential for the treatment of CNV‐associated diseases, such as age‐related macular degeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China.
- Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory of Carbon-Based Functional Materials and Devices, Soochow University, Suzhou, 215123, China.
- Department of Ophthalmology, Lixiang Eye Hospital of Soochow University, Suzhou, 215123, China.
- Department of Ophthalmology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China.
ORCID-Profile: Lichen Yin
Förderung
- Natural Science Foundation of Jiangsu Province
- National Natural Science Foundation of China
- Jiangsu Key Research and Development Plan
- Collaborative Innovation Center of Suzhou Nano Science & Technology
- 111 project
- Joint International Research Laboratory of Carbon-Based FunctionalMaterials and Devices
- Suzhou Key Laboratory of Nanotechnology and Biomedicine
- Higher Education Discipline Innovation Project
Zitieren
APA
Liu, X., Zhao, Z., Li, W., Ren, M., Zhang, H., Cao, D., Wang, Y., Yang, H., Li, Y., Zhu, M., Xie, L., & Yin, L. (2025). Rationally Engineering Pro‐Proteins and Membrane‐Penetrating α‑Helical Polypeptides for Genome Editing Toward Choroidal Neovascularization Treatment. Advanced Materials. https://doi.org/10.1002/adma.202412366
Vancouver
Liu X, Zhao Z, Li W, Ren M, Zhang H, Cao D, et al. Rationally Engineering Pro‐Proteins and Membrane‐Penetrating α‑Helical Polypeptides for Genome Editing Toward Choroidal Neovascularization Treatment. Advanced Materials. 2025. doi:10.1002/adma.202412366
BibTeX
@article{Liu2025,
author = {Liu, Xun and Zhao, Ziyin and Li, Wei and Ren, Mengyao and Zhang, Haoyu and Cao, Desheng and Wang, Yehan and Yang, He and Li, Yajie and Zhu, Manhui and Xie, Laiqing and Yin, Lichen},
title = {Rationally Engineering Pro‐Proteins and Membrane‐Penetrating α‑Helical Polypeptides for Genome Editing Toward Choroidal Neovascularization Treatment},
journal = {Advanced Materials},
year = {2025},
doi = {10.1002/adma.202412366}
}
EUVIMED